Carmela Coccia

Div. Of Rheumatology, AOU Careggi
Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Journal: Clinical rheumatology

Published: January 19, 2026

Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience.

Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience.

Journal: Reumatismo

Published: January 31, 2025

The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases.

The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases.

Journal: Biomedicines

Published: June 26, 2024

Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort.

Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort.

Journal: Clinical and experimental medicine

Published: January 08, 2024

Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.

Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.

Journal: RMD open

Published: June 23, 2023

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases.

Journal: Journal of personalized medicine

Published: March 08, 2023

Circulating Calprotectin (cCLP) in autoimmune diseases.

Circulating Calprotectin (cCLP) in autoimmune diseases.

Journal: Autoimmunity reviews

Published: January 25, 2023

JAK inhibitors and autoimmune rheumatic diseases.

JAK inhibitors and autoimmune rheumatic diseases.

Journal: Autoimmunity reviews

Published: January 02, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026